Significant findings from a recent AMRA imaging analysis study, which were presented last week at the 2024 European Congress on Obesity, glean insight into the role of adverse muscle composition in mortality risk in obesity
Medical Research
AMRA Medical’s Muscle Composition Analysis Used to Evaluate the Effect of Liraglutide Treatment in Obesity
Results from a randomized, double-blind trial in diabetes-free adults living with obesity and high cardiovascular disease risk showed that liraglutide was associated with a reduction in both muscle fat infiltration and prevalence of adverse muscle composition when compared to placebo
Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study
The comprehensive ACCESS-ESLD study aims to validate novel biomarkers and imaging techniques for screening of hepatocellular carcinoma and sarcopenia in liver cirrhosis patients using a rapid, non-invasive clinical surveillance methodology, powered by AMRA’s MRI-based body composition technology
AMRA Medical’s Innovative Fat Z-Score Biomarkers Show Tirzepatide Treatment is Associated with a Potential Targeted Effect on Visceral Fat and Liver Fat
Exploratory analysis from the SURPASS-3 MRI study shows significant reduction of both visceral- and liver fat z-scores, and a shift towards a…
New AMRA Medical Insights Shared at ICFSR 2024 Correlate Adverse Muscle Composition in Chronic Kidney Disease with Poor Functional Performance & Increased Comorbidity
A recent study reveals how muscle composition markers derived from AMRA’s innovative MRI-based body composition platform can identify vulnerable individuals within CKD…
Latest AMRA Medical Findings Presented at ICFSR 2024 Link Muscle Composition with Function, Strength, and Physical Performance
A recent AMRA study associates function, strength & mobility with MRI-powered muscle composition markers in the acclaimed SOMMA study LINKÖPING, Sweden, March…